These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26365492)

  • 1. Evaluation of initial dofetilide dosing recommendation based on actual body weight in overweight and obese patients.
    Cao DX; Kohatsu A; Eng L; Mei K; Dinh J; Mok I; Moreau N; Le A; Shin J
    J Clin Pharm Ther; 2015 Dec; 40(6):635-9. PubMed ID: 26365492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dofetilide-Associated QT Prolongation: Total Body Weight Versus Adjusted or Ideal Body Weight for Dosing.
    Wang SY; Welch TD; Sangha RS; Maloney RW; Cui Z; Kaplan AV
    J Cardiovasc Pharmacol; 2018 Sep; 72(3):161-165. PubMed ID: 29985283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin Glargine Dose and Weight Changes in Underweight, Normal Weight, and Overweight Children Newly Diagnosed with Type 1 Diabetes Mellitus.
    Chalk BS; Crane J; Yenokyan G; Pineda EM; Lee CKK
    Pharmacotherapy; 2019 Jul; 39(7):741-748. PubMed ID: 31102482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase IV trial evaluating the effectiveness and safety of dofetilide.
    Guanzon AV; Crouch MA
    Ann Pharmacother; 2004; 38(7-8):1142-7. PubMed ID: 15161945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dofetilide dose calculation errors in elderly associated with use of the modification of diet in renal disease equation.
    Denetclaw TH; Oshima N; Dowling TC
    Ann Pharmacother; 2011 Jul; 45(7-8):e44. PubMed ID: 21712508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ideal Body Weight Is Useful For Predicting Neutrophil Engraftment and Platelet Recovery for Overweight and Obese Recipients in Single-Unit Cord Blood Transplantation.
    Okada Y; Nakasone H; Konuma T; Uchida N; Tanaka M; Sugio Y; Aotsuka N; Nishijima A; Katsuoka Y; Ara T; Ota S; Onizuka M; Sawa M; Kimura T; Fukuda T; Atsuta Y; Kanda J; Kimura F
    Transplant Cell Ther; 2022 Aug; 28(8):504.e1-504.e7. PubMed ID: 35577325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjusting eptifibatide doses for renal impairment: a model of dosing agreement among various methods of estimating creatinine clearance.
    Healy MF; Speroni KG; Eugenio KR; Murphy PM
    Ann Pharmacother; 2012 Apr; 46(4):477-83. PubMed ID: 22474135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Body Mass Index and Weight-Adjusted Fluid Dosing on Mortality in Sepsis.
    Ward MA; Kuttab HI; Lykins V JD; Wroblewski K; Hughes MD; Keast EP; Kopec JA; Rourke EM; Purakal J
    J Intensive Care Med; 2022 Jan; 37(1):83-91. PubMed ID: 33213268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dofetilide dose reductions and discontinuations in women compared with men.
    Pokorney SD; Yen DC; Campbell KB; Allen LaPointe NM; Sheng S; Thomas L; Bahnson TD; Daubert JP; Picini JP; Jackson KP; Thomas KL; Al-Khatib SM
    Heart Rhythm; 2018 Apr; 15(4):478-484. PubMed ID: 29605013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dofetilide Dose Reductions and Discontinuation in Obese Compared with Nonobese Patients.
    Anderson K; Greenlee K; Matteo M; Wilkoff B
    J Cardiovasc Pharmacol; 2022 Dec; 80(6):820-825. PubMed ID: 35976119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional range of creatinine clearance for renal drug dosing: a practical solution to the controversy of which weight to use in the Cockcroft-Gault equation.
    Brown DL; Masselink AJ; Lalla CD
    Ann Pharmacother; 2013; 47(7-8):1039-44. PubMed ID: 23757387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of various body weights and serum creatinine concentrations on the bias and accuracy of the Cockcroft-Gault equation.
    Winter MA; Guhr KN; Berg GM
    Pharmacotherapy; 2012 Jul; 32(7):604-12. PubMed ID: 22576791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of phenytoin loading doses in overweight patients using actual versus adjusted body weight.
    Keats K; Powell R; Rocker J; Waller J; Coppiano LS
    Epilepsy Behav; 2022 Sep; 134():108833. PubMed ID: 35839643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous magnesium sulfate enhances the ability of dofetilide to successfully cardiovert atrial fibrillation or flutter: results of the Dofetilide and Intravenous Magnesium Evaluation.
    Coleman CI; Sood N; Chawla D; Talati R; Ghatak A; Kluger J;
    Europace; 2009 Jul; 11(7):892-5. PubMed ID: 19351630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboplatin dose calculation in lung cancer patients with low serum creatinine concentrations using CKD-EPI and Cockcroft-Gault with different weight descriptors.
    Kaag D
    Lung Cancer; 2013 Jan; 79(1):54-8. PubMed ID: 23131495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unfractionated heparin dosing for venous thromboembolism in morbidly obese patients: case report and review of the literature.
    Myzienski AE; Lutz MF; Smythe MA
    Pharmacotherapy; 2010 Mar; 30(3):324. PubMed ID: 20180615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ideal rather than actual body weight should be used to calculate cell dose in allogeneic hematopoietic stem cell transplantation.
    Singhal S; Gordon LI; Tallman MS; Winter JN; Evens AM; Frankfurt O; Williams SF; Grinblatt D; Kaminer L; Meagher R; Mehta J
    Bone Marrow Transplant; 2006 Mar; 37(6):553-7. PubMed ID: 16444282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analysis of measured and estimated creatinine clearance rates in normal weight, overweight, and obese patients with gynecologic cancers.
    Nelson WK; Formica RN; Cooper DL; Schwartz PE; Rutherford TJ
    J Oncol Pharm Pract; 2012 Sep; 18(3):323-32. PubMed ID: 22331238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary artery disease potentiates response to dofetilide for rhythm control of atrial fibrillation.
    Manocha P; Bavikati V; Langberg J; Lloyd MS
    Pacing Clin Electrophysiol; 2012 Feb; 35(2):170-3. PubMed ID: 22017595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of oral dofetilide for rhythm control of atrial fibrillation and atrial flutter.
    Abraham JM; Saliba WI; Vekstein C; Lawrence D; Bhargava M; Bassiouny M; Janiszewski D; Lindsay B; Militello M; Nissen SE; Poe S; Tanaka-Esposito C; Wolski K; Wilkoff BL
    Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):772-6. PubMed ID: 26063741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.